8-K/A
filed November 27, 2024, 6:59 PM ET
ticker RXRX
CIK 0001601830
M&A
confidence high
sentiment neutral
materiality 0.75
Recursion completes Exscientia acquisition; pro forma shows increased net losses
RECURSION PHARMACEUTICALS, INC.
- Total purchase price ~$635.9M; transaction closed Nov 20, 2024.
- Pro forma 2023 net loss of $548.7M ($1.74/share) vs Recursion standalone $328.1M.
- Pro forma 9M 2024 net loss of $476.5M ($1.32/share) vs Recursion standalone $284.8M.
- Combined total assets ~$1.55B, equity ~$1.14B as of Sept 30, 2024.
- Goodwill of $76.9M and intangible assets of $355.1M recorded.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001601830-24-000229
- form_type
- 8-K/A
- ticker
- RXRX
- cik
- 0001601830
- company_name
- RECURSION PHARMACEUTICALS, INC.
- filed_at
- 2024-11-27T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:08.935590+00:00
- generated_at
- 2026-05-29T14:15:31.340844+00:00
- sec_items
- ["9.01"]
- event_type
- m_and_a
- sentiment
- neutral
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001601830-24-000229
- json_url
- https://secwatch.observer/filing/0001601830-24-000229.json
- markdown_url
- https://secwatch.observer/filing/0001601830-24-000229.md
- text_url
- https://secwatch.observer/filing/0001601830-24-000229.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183024000229/0001601830-24-000229-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183024000229/rxrx-20241119.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
FFIC
OceanFirst completes acquisition of Flushing Financial; FFIC holders receive 0.85 OCFC shares
FLUSHING FINANCIAL CORP
June 1, 2026, 5:21 PM ET
m_and_a
Items 2.01, 3.01, 3.03, 5.01, 5.02, 9.01
same SEC item: 9.01
same event type: m_and_a
similar materiality
Filing page
SEC filing
TACH
Titan Acquisition Corp enters $800M deal to combine with OpenPayd
Titan Acquisition Corp.
June 1, 2026, 5:15 PM ET
m_and_a
Items 1.01, 7.01, 9.01
same SEC item: 9.01
same event type: m_and_a
similar materiality
Filing page
SEC filing
AROW
Arrow Financial receives OCC approval for Adirondack Bancorp merger; close expected July 1, 2026
ARROW FINANCIAL CORP
June 1, 2026, 4:30 PM ET
m_and_a
Items 8.01, 9.01
same SEC item: 9.01
same event type: m_and_a
similar materiality
Filing page
SEC filing
ZSQR
Z Squared OpCo reports $323K net loss for 2025, no revenue, going concern
Z Squared Inc.
June 1, 2026, 4:30 PM ET
m_and_a
Items 9.01
same SEC item: 9.01
same event type: m_and_a
similar materiality
Filing page
SEC filing
CYH
Community Health Systems closes sale of four Arkansas hospitals for $110M cash to Freeman Health System
COMMUNITY HEALTH SYSTEMS INC
June 1, 2026, 4:30 PM ET
m_and_a
Items 2.01, 9.01, 8.01
same SEC item: 9.01
same event type: m_and_a
similar materiality
Filing page
SEC filing
AWK
American Water completes $315M acquisition of Nexus Water systems in eight states
American Water Works Company, Inc.
June 1, 2026, 4:24 PM ET
m_and_a
Items 8.01, 9.01
same SEC item: 9.01
same event type: m_and_a
similar materiality
Filing page
SEC filing
RPAY
REPAY closes $372M acquisition of KUBRA, funded with new $500M term loan
Repay Holdings Corp
June 1, 2026, 4:14 PM ET
m_and_a
Items 1.01, 2.01, 1.02, 9.01, 2.03, 7.01
same SEC item: 9.01
same event type: m_and_a
similar materiality
Filing page
SEC filing
BHR
Braemar completes sale of Park Hyatt Beaver Creek for $176M; repays $86.25M convertible notes
Braemar Hotels & Resorts Inc.
June 1, 2026, 4:11 PM ET
m_and_a
Items 2.01, 7.01, 8.01, 9.01
same SEC item: 9.01
same event type: m_and_a
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.